| Cancer Cells and Metastasis | Lifetime | 180 | US 89 | 99.07 |
| Cancer-related molecular mechanisms research | Lifetime | 569 | US 153 | 98.32 |
| Epigenetics and DNA Methylation | Lifetime | 694 | US 362 | 98.38 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 699 | US 344 | 98.24 |
| Wnt/β-catenin signaling in development and cancer | Lifetime | 165 | US 76 | 97.70 |
| MicroRNA in disease regulation | Lifetime | 880 | US 242 | 97.53 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 393 | US 180 | 97.84 |
| Cancer-related Molecular Pathways | Lifetime | 575 | US 319 | 98.04 |
| Cancer-related gene regulation | Lifetime | 505 | US 238 | 97.55 |
| Immune cells in cancer | Lifetime | 522 | US 220 | 97.23 |
| Virus-based gene therapy research | Lifetime | 917 | US 543 | 97.65 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 388 | US 226 | 96.97 |
| Circular RNAs in diseases | Lifetime | 785 | US 136 | 95.83 |
| Autophagy in Disease and Therapy | Lifetime | 714 | US 238 | 95.86 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 396 | US 200 | 95.89 |
| Cancer Mechanisms and Therapy | Lifetime | 586 | US 240 | 94.52 |
| Hedgehog Signaling Pathway Studies | Lifetime | 571 | US 275 | 93.25 |
| Beetle Biology and Toxicology Studies | Lifetime | 840 | US 182 | 44.91 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 57 | US 16 | 97.74 |
| Immune cells in cancer | 2021-2025 | 102 | US 17 | 97.50 |
| MicroRNA in disease regulation | 2021-2025 | 222 | US 16 | 97.14 |
| Epigenetics and DNA Methylation | 2021-2025 | 357 | US 116 | 94.58 |
| Circular RNAs in diseases | 2021-2025 | 280 | US 14 | 94.19 |
| Cancer Cells and Metastasis | 2021-2025 | 328 | US 95 | 91.19 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 75 | US 38 | 90.42 |
| Virus-based gene therapy research | 2021-2025 | 504 | US 175 | 89.98 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 246 | US 52 | 83.87 |
| Autophagy in Disease and Therapy | 2021-2025 | 792 | US 104 | 83.82 |
| Cancer Research and Treatments | 2021-2025 | 651 | US 178 | 82.08 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 124 | US 32 | 79.04 |
| Cancer Mechanisms and Therapy | 2021-2025 | 518 | US 71 | 80.34 |
| Galectins and Cancer Biology | 2021-2025 | 597 | US 107 | 71.98 |
| Biochemical effects in animals | 2021-2025 | 983 | US 69 | 66.37 |
| Cell death mechanisms and regulation | 2021-2025 | 685 | US 120 | 50.88 |
| NF-κB Signaling Pathways | 2021-2025 | 452 | US 58 | 51.97 |
| Chemokine receptors and signaling | 2021-2025 | 878 | US 190 | 48.68 |
| TGF-β signaling in diseases | 2021-2025 | 418 | US 89 | 43.34 |
